{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:33:45Z","timestamp":1794018825227,"version":"4.8.0"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Inorganic Biochemistry"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jinorgbio.2021.111695","type":"journal-article","created":{"date-parts":[[2021,12,29]],"date-time":"2021-12-29T11:15:59Z","timestamp":1640776559000},"page":"111695","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Biocompatible silver(I) complexes with heterocyclic thioamide ligands for selective killing of cancer cells and high antimicrobial activity \u2013 A combined in vitro and in silico study"],"prefix":"10.1016","volume":"228","author":[{"given":"Despoina","family":"Varna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Geromichalou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Papachristou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rigini","family":"Papi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonios G.","family":"Hatzidimitriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Panteris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Psomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George D.","family":"Geromichalos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paraskevas","family":"Aslanidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodora","family":"Choli-Papadopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis A.","family":"Angaridis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinorgbio.2021.111695_bb0005","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0010","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1002\/ejic.200600723","article-title":"Classical and non-classical ruthenium-based anticancer drugs: towards targeted chemotherapy","author":"Han Ang","year":"2006","journal-title":"Eur. J. Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0015","doi-asserted-by":"crossref","first-page":"12888","DOI":"10.1039\/D0SC04082G","article-title":"Metallodrugs are unique: opportunities and challenges of discovery and development","volume":"11","author":"Anthony","year":"2020","journal-title":"Chem. Sci."},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0020","series-title":"Binding, Transport and Storage of Metal Ions in Biological Cells","first-page":"429","author":"Arnesano","year":"2014"},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0025","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S1367-5931(03)00081-4","article-title":"New metal complexes as potential therapeutics","volume":"7","author":"Zhang","year":"2003","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0030","series-title":"Metals in Medicine","author":"Dabrowiak","year":"2009"},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0035","doi-asserted-by":"crossref","first-page":"6894","DOI":"10.1039\/b906308k","article-title":"Metal-NHC complexes: a survey of anti-cancer properties","volume":"21","author":"Teyssot","year":"2009","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0040","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1071\/CH11132","article-title":"Recent advances in mapping the sub-cellular distribution of metal-based anticancer drugs","volume":"64","author":"Wedlock","year":"2011","journal-title":"Aust. J. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0045","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/med.20168","article-title":"Gold compounds as anticancer agents: chemistry, cellular pharmacology, and preclinical studies","volume":"30","author":"Nobili","year":"2010","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0050","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.procbio.2019.10.022","article-title":"Next generation sequencing and functional pathway analysis to understand the mechanism of action of copper-tolfenamic acid against pancreatic cancer cells","volume":"89","author":"Hurtado","year":"2020","journal-title":"Process Biochem."},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0055","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1021\/cr400135x","article-title":"Advances in copper complexes as anticancer agents","volume":"114","author":"Santini","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0060","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1155\/MBD.1994.467","article-title":"Antibacterial silver","volume":"1","author":"Clement","year":"1994","journal-title":"Met Based Drugs"},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0065","first-page":"575","article-title":"Synthesis, antiproliferative and antimalarial activities of dinuclear silver(I) complexes with triphenylphosphine and thiosemicarbazones ligands, indones","volume":"21","author":"Mohd Khir","year":"2021","journal-title":"J. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0070","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejmech.2012.11.038","article-title":"Synthesis, structures, and antimalarial activities of some silver(I), gold(I) and gold(III) complexes involving N-heterocyclic carbene ligands","volume":"60","author":"Hemmert","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0075","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s10616-017-0070-y","article-title":"Apoptosis-inducing ability of silver(I) cyanide-phosphines useful for anti-cancer studies","volume":"69","author":"Human-Engelbrecht","year":"2017","journal-title":"Cytotechnology"},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0080","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3390\/molecules21020087","article-title":"Antibacterial activity and cytotoxicity of silver(I) complexes of pyridine and (benz)imidazole derivatives. X-ray crystal structure of [Ag(2,6-di(CH2OH)py)2]NO3","volume":"21","author":"Kalinowska-Lis","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0085","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1128\/AAC.5.6.582","article-title":"Mechanism of silver sulfadiazine action on burn wound infections","volume":"5","author":"Fox","year":"1974","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0090","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0305-4179(99)00108-4","article-title":"Historical review of the use of silver in the treatment of burns. I. Early uses","volume":"26","author":"Klasen","year":"2000","journal-title":"Burns."},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0095","doi-asserted-by":"crossref","first-page":"4708","DOI":"10.1021\/cr300288v","article-title":"Nanobio silver: its interactions with peptides and bacteria, and its uses in medicine","volume":"113","author":"Eckhardt","year":"2013","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jhin.2004.11.014","article-title":"Bacterial resistance to silver in wound care","volume":"60","author":"Percival","year":"2005","journal-title":"J. Hosp. Infect."},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0105","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2147\/DDDT.S119488","article-title":"Metal complexes in cancer therapy \u2013 an update from drug design perspective","volume":"11","author":"Ndagi","year":"2017","journal-title":"Drug Des Devel Ther."},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0110","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1039\/c3mt00046j","article-title":"Anti-proliferative and anti-tumor activity of silver(I) compounds","volume":"5","author":"Banti","year":"2013","journal-title":"Metallomics"},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0115","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1081\/SIM-200055672","article-title":"Strong silver-silver interactions in three silver(I) carboxylate complexes with high cytotoxicity properties","volume":"35","author":"Liu","year":"2005","journal-title":"Synth. React. Inorg. Met. Org., Nano Met. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0120","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jinorgbio.2010.10.016","article-title":"In vitro antitumour activity of water soluble Cu(I), Ag(I) and Au(I) complexes supported by hydrophilic alkyl phosphine ligands","volume":"105","author":"Santini","year":"2011","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0125","doi-asserted-by":"crossref","first-page":"15470","DOI":"10.1039\/C9RA01804B","article-title":"Silver derivatives of multi-donor heterocyclic thioamides as antimicrobial\/anticancer agents: unusual bioactivity against methicillin resistant S. aureus, S. epidermidis, and E. faecalis and human bone cancer MG63 cell line","volume":"9","author":"Aulakh","year":"2019","journal-title":"RSC Adv."},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0130","doi-asserted-by":"crossref","first-page":"5484","DOI":"10.3390\/molecules25225484","article-title":"Antiproliferative homoleptic and heteroleptic phosphino silver(I) complexes: effect of ligand combination on their biological mechanism of action","volume":"25","author":"Dammak","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2020.111247","article-title":"Antibacterial activities and antiproliferative assays over a tumor cells panel of a silver complex with 4-aminobenzoic acid: studies in vitro of sustained release using bacterial cellulose membranes as support","volume":"212","author":"Aquaroni","year":"2020","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0140","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.msec.2019.01.107","article-title":"Homoleptic and heteroleptic silver(I) complexes bearing diphosphane and thioamide ligands: synthesis, structures, DNA interactions and antibacterial activity studies","volume":"99","author":"Varna","year":"2019","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0145","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.crci.2016.09.001","article-title":"Silver(I) thiosemicarbazone complex [Ag(catsc)(PPh3)2]NO3: synthesis, characterization, crystal structure, and antibacterial study","volume":"20","author":"Khalaji","year":"2017","journal-title":"C. R. Chim."},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0150","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.1016\/j.arabjc.2020.05.039","article-title":"In vitro biological studies of heteroleptic Ag(I) and Cu(I) unsymmetrical N,N\u2032-diarylformamidine dithiocarbamate phosphine complexes; the effect of the metal center","volume":"13","author":"Oladipo","year":"2020","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0155","doi-asserted-by":"crossref","first-page":"4830","DOI":"10.1039\/C4NJ02203C","article-title":"The structural and electronic impact on the photophysical and biological properties of a series of CuI and AgI complexes with triphenylphosphine and pyrimidine-type thiones","volume":"39","author":"Papanikolaou","year":"2015","journal-title":"New J. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0160","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s11243-008-9076-9","article-title":"Biologically active 2-thione-4,6-diamino-5-hydroxypyrimidine transition metal complexes","volume":"33","author":"Mostafa","year":"2008","journal-title":"Transit. Met. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0165","article-title":"Structural properties, cytotoxicity, and anti-inflammatory activity of silver(I) complexes with tris(p-tolyl)phosphine and 5-chloro-2-mercaptobenzothiazole","volume":"386860","author":"Kyros","year":"2010","journal-title":"Bioinorg. Chem. Appl."},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0170","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jorganchem.2019.04.018","article-title":"Novel silver-NHC complexes: synthesis and anticancer properties","volume":"891","author":"\u015eahin-B\u00f6l\u00fckba\u015f\u0131","year":"2019","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2020.128890","article-title":"Tri N-heterocyclic carbene trinuclear silver(I) complexes: synthesis and in vitro cytotoxicity studies","volume":"1222","author":"Fatima","year":"2020","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ica.2019.119357","article-title":"Silver(I) complexes with 1,10-phenanthroline-based ligands: the influence of epoxide function on the complex structure and biological activity","volume":"502","author":"Duri\u0107","year":"2020","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0185","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.poly.2017.09.041","article-title":"Luminescent Ag(I) scorpionates based on tris(2-pyridyl)phosphine oxide: Synthesis and cytotoxic activity evaluation","volume":"138","author":"Al","year":"2017","journal-title":"Polyhedron"},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0190","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0162-0134(88)80007-2","article-title":"Antimicrobial and anticancer activity of tetrahedral, chelated, diphosphine silver(I) complexes: comparison with copper and gold","volume":"33","author":"Berners-Price","year":"1988","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0195","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1080\/00958972.2017.1366466","article-title":"Anticancer activity of silver(I) cyclohexyldiphenylphosphine complexes towards SNO cancer cells","volume":"70","author":"Potgieter","year":"2017","journal-title":"J. Coord. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0200","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/527123","article-title":"Synthesis, structure, and anticancerous properties of silver complexes","volume":"2013","author":"Shukla","year":"2013","journal-title":"J. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0205","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.3390\/cancers12123848","article-title":"Light stability, pro-apoptotic and genotoxic properties of silver (I) complexes of metronidazole and 4-hydroxymethylpyridine against pancreatic cancer cells in vitro","volume":"12","author":"\u017byro","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0210","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.ica.2007.07.034","article-title":"Tetrameric 1:1 and monomeric 1:3 complexes of silver(I) halides with tri(p-tolyl)-phosphine: a structural and biological study","volume":"362","author":"Zartilas","year":"2009","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0215","doi-asserted-by":"crossref","first-page":"953","DOI":"10.2147\/IJN.S225038","article-title":"Synthesis, characterization and DNA binding investigations of a new binuclear Ag(I) complex and evaluation of its anticancer property","volume":"15","author":"Zheng","year":"2020","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0220","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/ejic.200300672","article-title":"Synthesis, characterization and in vitro study of the cytostatic and antiviral activity of new polymeric silver(I) complexes with ribbon structures derived from the conjugated heterocyclic thioamide 2-mercapto-3,4,5,6-tetra- hydropyrimidine","volume":"4","author":"Zachariadis","year":"2004","journal-title":"Eur. J. Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0225","doi-asserted-by":"crossref","first-page":"8395374","DOI":"10.1155\/2018\/8395374","article-title":"New silver complexes with mixed thiazolidine and phosphine ligands as highly potent antimalarial and anticancer agents","volume":"2018","author":"Mohd Sofyan","year":"2018","journal-title":"J. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0230","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.poly.2018.05.020","article-title":"Heterocyclic thioamide\/phosphine mixed-ligand silver(I) complexes: synthesis, molecular structures, DNA-binding properties and antibacterial activity","volume":"151","author":"Varna","year":"2018","journal-title":"Polyhedron"},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2020.111167","article-title":"Silver complexes with heterocyclic thioamide and tertiary arylphosphane ligands: synthesis, crystal structures, in vitro and in silico antibacterial and cytotoxic activity, and interaction with DNA","volume":"210","author":"Anastasiadou","year":"2020","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0240","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1039\/a901322i","article-title":"Potentiometric and spectroscopic evidence for co-ordination of dimethyltin(IV) to phosphate groups of DNA fragments and related ligands","volume":"10","author":"Jancs\u00f3","year":"1999","journal-title":"J. Chem. Soc. Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0245","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0162-0134(96)00039-6","article-title":"Diorganotin(IV) antitumor agent. (C2H5)2SnCl2(phen)\/nucleotides aqueous and solid-state coordination chemistry and its DNA binding studies","volume":"64","author":"Li","year":"1996","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0250","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/1099-0739(200011)14:11<727::AID-AOC68>3.0.CO;2-H","article-title":"Organotin adducts with pyrimidinethione: crystal structure of dimethyldi(pyrimidine-2-thiolato)tin(IV) and diphenyldi(pyrimidine-2-thiolato)tin(IV)","volume":"14","author":"Hadjikakou","year":"2000","journal-title":"Appl. Organomet. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.poly.2019.114235","article-title":"Synthesis, structures, and novel antimicrobial activity of silver(I) halide complexes of imidazolidine-2-thiones","volume":"175","author":"Aulakh","year":"2020","journal-title":"Polyhedron"},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0260","series-title":"The Elements","first-page":"174","author":"Emsley","year":"1989"},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0265","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1016\/j.ica.2004.06.011","article-title":"Trans-1,2-bis(diphenylphosphino)ethene as bridging ligand in thione-S-ligated dimeric copper(I) chloride complexes","volume":"357","author":"Aslanidis","year":"2004","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0270","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/0022-1902(74)80503-8","article-title":"Thioamide bands and nature of bonding \u2013 II","volume":"36","author":"Singh","year":"1974","journal-title":"J. Inorg. Nucl. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0275","series-title":"Medical Microbiology","author":"Murray","year":"2020"},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0280","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ejmech.2014.03.028","article-title":"A novel silver iodide metalo-drug: experimental and computational modelling assessment of its interaction with intracellular DNA, lipoxygenase and glutathione","volume":"77","author":"Banti","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.ica.2021.120316","article-title":"Ag(I) symmetrical N,N\u2032-diarylformamidine dithiocarbamate PPh3 complexes: Synthesis, structural characterization, quantum chemical calculations and in vitro biological studies","volume":"520","author":"Oladipo","year":"2021","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0290","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.2217\/fon.09.127","article-title":"New hopes from old drugs: revisiting DNA-binding small molecules as anticancer agents","volume":"5","author":"Gurova","year":"2009","journal-title":"Future Oncol."},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0295","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0301-4622(93)E0101-A","article-title":"Fluorescence lifetime analysis of DNA intercalated ethidium bromide and quenching by free dye","volume":"50","author":"Heller","year":"1994","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0300","series-title":"Principles of Fluorescence Spectroscopy","author":"Lakowicz","year":"2006"},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0305","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.molimm.2012.05.011","article-title":"Structural and immunologic characterization of bovine, horse, and rabbit serum albumins","volume":"52","author":"Majorek","year":"2010","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0310","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0167-4838(01)00287-4","article-title":"Interaction of bovine (BSA) and human (HSA) serum albumins with ionic surfactants: spectroscopy and modelling","volume":"1594","author":"Gelamo","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0315","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jmb.2005.07.075","article-title":"Structural basis of the drug-binding specificity of human serum albumin","volume":"353","author":"Ghuman","year":"2005","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0320","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2174\/1381612802666220921174531","article-title":"Type II DNA topoisomerases as antibacterial targets","volume":"2","author":"Shen","year":"1996","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0325","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1021\/bi00061a033","article-title":"The 43-kilodalton N-terminal fragment of the DNA gyrase B protein hydrolyzes ATP and binds coumarin drugs","volume":"32","author":"Ali","year":"1993","journal-title":"Biochemistry"},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0330","doi-asserted-by":"crossref","first-page":"9801","DOI":"10.1021\/bi00030a018","article-title":"Nucleotide binding to the 43-kilodalton N-terminal fragment of the DNA gyrase B protein","volume":"34","author":"Ali","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0335","first-page":"3424s","article-title":"Antiestrogen treatment of breast cancer: an overview","volume":"42","author":"Pearson","year":"1982","journal-title":"Cancer Res."},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1758835918786451","article-title":"CDK4\/6 inhibition in breast cancer: current practice and future directions","volume":"10","author":"Pernas","year":"2018","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0345","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3390\/cancers7010179","article-title":"Targeting cyclin-dependent kinases in human cancers: from small molecules to peptide inhibitors","volume":"7","author":"Peyressatre","year":"2015","journal-title":"Cancers"},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0350","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/0092-8674(93)90636-5","article-title":"Mammalian G1 cyclins","volume":"73","author":"Sherr","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0355","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1080\/15384101.2015.1084445","article-title":"Targeting CDK6 in cancer: state of the art and new insights","volume":"14","author":"Tadesse","year":"2015","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0360","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11912-004-0024-3","article-title":"Small molecule inhibitors targeting cyclin-dependent kinases as anticancer agents","volume":"6","author":"Dai","year":"2004","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0365","first-page":"235","article-title":"Cyclin-dependent kinase inhibitors","volume":"5","author":"Fischer","year":"2003","journal-title":"Prog. Cell Cycle Res."},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0370","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1634\/theoncologist.2014-0443","article-title":"The role of CDK4\/6 inhibition in breast cancer","volume":"20","author":"Murphy","year":"2015","journal-title":"The Onclologist"},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0375","first-page":"2315","article-title":"17beta-estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells","volume":"12","author":"Altucci","year":"1996","journal-title":"Oncogene"},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0380","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1210\/me.2013-1065","article-title":"Cyclin D1 determines estrogen signaling in the mammary gland in vivo","volume":"27","author":"Casimiro","year":"2013","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0385","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1530\/ERC-10-0262","article-title":"Therapeutically activating RB: reestablishing cell cycle control in endocrine therapy-resistant breast cancer","volume":"18","author":"Thangavel","year":"2011","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0390","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.virol.2008.11.017","article-title":"Papillomavirus E6 proteins","volume":"384","author":"Howie","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0395","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00705-007-0022-5","article-title":"Cellular binding partners of the human papillomavirus E6 protein","volume":"153","author":"Tungteakkhun","year":"2008","journal-title":"Arc. Virol."},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0400","doi-asserted-by":"crossref","first-page":"7542","DOI":"10.1073\/pnas.1304855110","article-title":"HPV-18 E6 mutants reveal p53 modulation of viral DNA amplification in organotypic cultures","volume":"110","author":"Kho","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0405","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0092-8674(93)90384-3","article-title":"The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53","volume":"75","author":"Scheffner","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0410","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1126\/science.1905840","article-title":"p53 mutations in human cancers","volume":"253","author":"Hollstein","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.jinorgbio.2021.111695_bb0415","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12860-019-0214-3","article-title":"Identification of potential binding pocket on viral oncoprotein HPV16 E6: a promising anti-cancer target for small molecule drug discovery","volume":"20","author":"Kolluru","year":"2019","journal-title":"BMC Mol. Cell Biol."}],"container-title":["Journal of Inorganic Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0162013421003421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0162013421003421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T15:05:26Z","timestamp":1758985526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0162013421003421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":83,"alternative-id":["S0162013421003421"],"URL":"https:\/\/doi.org\/10.1016\/j.jinorgbio.2021.111695","relation":{},"ISSN":["0162-0134"],"issn-type":[{"value":"0162-0134","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biocompatible silver(I) complexes with heterocyclic thioamide ligands for selective killing of cancer cells and high antimicrobial activity \u2013 A combined in vitro and in silico study","name":"articletitle","label":"Article Title"},{"value":"Journal of Inorganic Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinorgbio.2021.111695","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111695"}}